For health stakeholders
Educating key stakeholders about new perspectives as well as the already existing methods to prevent and control allergies and asthma are vital to combating the diseases beyond symptoms.
One of the therapy methods is allergen immunotherapy: a cost-efficient and disease-modifying intervention that prevents new sensitisations and asthma. Immunotherapy is currently the only medical intervention with proven efficacy that could potentially shift the global increase trajectory of allergic diseases.
Get Campaign Resources that provide you with all the resources needed for building a convincing argument, including science-based evidence.
Last updated 28 April 2016